Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SFC vs FP vs Placebo on Airway Inflammation in Asthma
NCT00517634Phase 4Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of salmeterol + fluticasone in asthma (6 arms), sponsored by GSK. Primary endpoint: Weighted Mean Change From Baseline Over 0-6 Hours in Blood Eosinophils Post-Allergen Challenge at Day 35. Started Aug 2007; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00517634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517634.